These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3770260)

  • 1. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases.
    Tosti A
    Dermatologica; 1986; 173(3):136-8. PubMed ID: 3770260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.
    Olsen EA; Weiner MS; Amara IA; DeLong ER
    J Am Acad Dermatol; 1990 Apr; 22(4):643-6. PubMed ID: 2180995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three percent topical minoxidil therapy for female androgenetic alopecia.
    Hordinsky MK; Shank J
    Clin Dermatol; 1988; 6(4):213-7. PubMed ID: 3214822
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical minoxidil: review of efficacy and safety.
    Katz HI
    Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical minoxidil therapy for androgenetic alopecia.
    Epstein E
    Arch Dermatol; 1988 Mar; 124(3):322-3. PubMed ID: 3345081
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
    Roberts J; Desai N; McCoy J; Goren A
    Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
    Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
    Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse hypertrichosis during treatment with 5% topical minoxidil.
    Peluso AM; Misciali C; Vincenzi C; Tosti A
    Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia.
    Thuangtong R; Thanomkitti K; Suvanasuthi S
    J Med Assoc Thai; 2017 Jan; 100(1):70-7. PubMed ID: 29911772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical minoxidil therapy in hereditary androgenetic alopecia.
    De Villez RL
    Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tretinoin for hair growth promotion.
    Bazzano GS; Terezakis N; Galen W
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):880-3, 890-3. PubMed ID: 3771854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia.
    Shi YP
    Arch Dermatol; 1986 May; 122(5):506. PubMed ID: 3707163
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
    Clissold SP; Heel RC
    Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.